Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10708830 | 0.98 | TSHR (0.38) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL10713524 | 0.98 | TSHR (0.38) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL10711206 | 0.98 | TSHR (0.33) | TSHRALDH1A1 | |
| SCHEMBL9789297 | 0.98 | TSHR (0.38) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL9789262 | 0.98 | TSHR (0.38) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL9789331 | 0.96 | TSHR (0.37) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL10712198 | 0.96 | TSHR (0.37) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL6664827 | 0.96 | TSHR (0.37) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL10712083 | 0.96 | TSHR (0.37) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL10711996 | 0.96 | TSHR (0.37) | TSHRALDH1A1LMNAABCC4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1403238-B1 | PROCESS FOR PRODUCING FLUORINATED ALCOHOL | TOSOH F TECH INC (JP) | 2007-04-04 | — | — | EP | disclosed |
| US-6894197-B2 | Reacting 4,4,4-trifluorobutylhalides with potassium salt of 4-hydroxybutyrate in gamma-butyrolactone solvents to form 4,4,4-trifluorobutanol; hydrolysis | TOSOH F-TECH, INC. (JP) | 2005-05-17 | — | — | US | disclosed |
| US-20040152926-A1 | Process for producing fluorinated alcohol | TOSOH F-TECH INC. (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-1403238-A1 | PROCESS FOR PRODUCING FLUORINATED ALCOHOL | Tosoh F-Tech, Inc. (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-4617363-A | ω-perfluoroalkyl-α-olefin polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-10-14 | — | — | US | disclosed |
| EP-0193202-A2 | Omega-perfluoroalkyl-alpha-olefin polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152926-A1 | Process for producing fluorinated alcohol | ADH1A, ADH1C, HSD17B10 | TSHR 1005/4885ALDH1A1 54/4885LMNA 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.